期刊文献+

甲强龙对实验性变态反应性脑脊髓炎小鼠的协同刺激分子CD80和CD86的影响 被引量:2

Effect of methylprednisolone on the levels of CD80 and CD86 in mice with experimental autoimmune encephalomyelitis
下载PDF
导出
摘要 目的探讨甲强龙对实验性变态反应性脑脊髓炎小鼠的协同刺激分子CD80和CD86的影响。方法实验性变态反应性脑脊髓炎(EAE)模型通过以髓鞘少突胶质细胞糖蛋白多肽35-55(MOG35-55)为抗原诱导。将30只雌性C57BL/6J小鼠随机分为甲强龙组、EAE组和正常组,每组10只。采用蛋白质印迹法检测大脑的CD80和CD86表达水平。结果甲强龙组神经功能缺损症状轻于EAE组,大脑CD80表达水平明显低于EAE组(P<0.05),而CD86表达明显高于EAE组(P<0.05)。结论甲强龙能改善EAE小鼠的症状,其作用机制之一是抑制CD80表达并上调CD86的表达。 Objective To explore the effect of methylprednisolone on the levels of cluster of differentiation (CD)80 and CD86 in the central nervous system of mice with experimental autoimmune encephalomyelitis(EAE). Methods The EAE model was induced in mice by immunized with myelin oligodendrocyte glycoprotein peptides (MOG35-55).30 female C57BL/6J mice were randomly divided into 3 groups: methylprednisolone-treated group, EAE group and normal group.The brain tissues were collected and their expressions of CD80 and CD86 were detected using western blot.Results The neurological deficits of the methylprednisolone-treated mice were lighter than those of the EAE mice(P〈0.05), while the methylprednisolone-treated mice displayed the lower expression of CD80 and the higher expression of CD86 than the EAE mice did(P〈0.05).Conclusion Methylprednisolone can protect a-gainst EAE in mice by the inhibition of CD80 and upregulation of CD86.
出处 《中国临床新医学》 2015年第5期416-418,共3页 CHINESE JOURNAL OF NEW CLINICAL MEDICINE
基金 广西医疗卫生重点科研课题项目(编号:重2010028) 广西自然科学基金项目(编号:2011GXNSFA018185) 国家自然科学基金资助项目(编号:81460192)
关键词 甲强龙 实验性变态反应性脑脊髓炎 多发性硬化 CD80 CD86 Methylprednisolone Experimental autoimmune encephalomyelitis (EAE) Multiple sclero-sis CD80 CD86
  • 相关文献

参考文献9

  • 1Chastain EM, Duncan DS, Rodgers JM, et al. The role of antigen presenting cells in multiple sclerosis [ J ]. Biochim Biophys Acta, 2011, 1812(2) : 265 -274.
  • 2Noseworthy JH, Lucchinetti C, Rodriguez M,et al. Multiple sclerosis [J]. N Engl J Med, 2000, 343(13) :938 -952.
  • 3陈玉社,公丕欣,杨明峰,夏作理.实验性变态反应性脑脊髓炎模型研究进展[J].国际神经病学神经外科学杂志,2005,32(6):533-536. 被引量:6
  • 4Hart BA, Gran B, Weissert R. EAE: imperfect but useful models of multiple sclerosis[J]. Trends Mol Med, 2011, 17(3): 1t9- 125.
  • 5Vanderheyde N, Verhasselt V, Goldman M, et al. Inhibition of hu- man dendritic cell funetions by methylprednisolone [ J ]. Transplanta- tion, 1999, 67(10) : 1342 - 1347.
  • 6Chen L. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity[ J]. Nat Rev Immunol, 2004, 4( 5 ) : 336 - 347.
  • 7Ceeraz S, Nowak EC, Noelle RJ. B7 family checkpoint regulators in immune regulation and disease [ J]. Trends Immunol, 2013, 34 ( 11 ) : 556 - 563.
  • 8Fife BT, Bluestone JA. Control of peripheral T-cell tolerance and au- toimmunity via the CTLA-4 and PD-1 pathways [ J]. Immunol Rev, 2008, 224:166 -182.
  • 9Miller SD, Vanderlugt CL, Lensehow DJ, et al. Blockade of CD28/ B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE [ J ]. Immunity, 1995, 3 (6) : 739 - 745.

二级参考文献19

  • 1Fuller KG, Olson JK, Howard LM, et al. Mouse Models of Multiple Sclerosis: Experimental Autoimmune Encephalomyelitisand Theiler' s Virus-Induced Demyelinating Disease. Methods Mol Med, 2004, 102(8): 339-362.
  • 2Sakuma H, Kohyama K, Park IK, et al. Clinicopathological study of a myelin oligodendrocyte glycoprotein-induceddemyelinating disease in LEW 1AV1 rats. Brain, 2004, 127 ( 10 ) :2201-2213.
  • 3Zhang GX, Baker GM. Chemokines and chemokine receptors in the pathogenesis of multiple sclerosis. Muh Scler, 2000, 6 ( 1 ) :3-13.
  • 4Mancardi G, Hart BA, Capello E, et al. Restricted immune responses lead to CNS demyelination and axonal damage. J Neuroimmunol, 2000, 107(2): 178-183.
  • 5Behi ME, Dubucquoi S, Lefranc D, et al. New insights into cell responses involved in experimental autoimnmnc encephalomyelitis and multiple sclerosis, Immunol Lett, 2005, 1 ( 1 ) : 11-26.
  • 6Rivero VE, Maccioni M, Bucher AE, et al. Suppression of experimental autoimnmne encephalomyelitis (EAE) by intraperitoneal administration of soluble myelin antigens in Wistar rats. J Neuroinununol, 1997, 72(1): 3-10.
  • 7Cowden WB, Cullen FA, Staykova MA, et al. Nitric oxide is a potential down-regulating molecule in autoimmune disease : Inhibition of nitric oxide production renders PCG rats highly susceptible to EAE. J Neuroimmunol, 1998, 88(1): 1-8.
  • 8Laman JD, van Meurs M, Schellekens MM, et al. Expression of accessory molecules and cytokines in acute EAE in marmoset monkey (Caallithrix jacchus). J Neuroimmunol, 1998, 86 ( 1 ) :30-45.
  • 9Teuschcr C, Bunn JY, Filhnore PD, et al. Gender, age, and season at immunization uniquely influence the genetic control of susceptibility to histopathological lesions and clinical signs of experimental allergic encephalomyelitis: implications for the genetics of multiple sclerosis. Am J Pathol, 2004, 165 ( 5 ) : 1593-1602.
  • 10Yu CY, Whitacre CC. Sex, MHC and complement C4 in autoimmune diseases. Trends Immunol, 2004, 25 ( 12 ) : 694-699.

共引文献5

同被引文献19

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部